Effect of Scapular Stabilization Exercises Versus Virtual Reality Exercises in Basketball Players With Scapular Dyskinesia (SD)

February 27, 2024 updated by: Nabil Mahmoud Ismail Abdel-Aal, Cairo University
this study will be conducted to compare virtual reality and scapular stabilizing exercise among basketball player with scapular dyskinesia on scapular muscle performance, rounded shoulder, pain intensity , disability and hand grip strength

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Scapular dyskinesia (SD) is an alteration in the normal position or motion of the scapula during coupled scapulohumeral movements. It is lack of control of static or dynamic positioning of the scapula relative to the thorax. It affects from 64% to 100% of patients with shoulder lesions. Scapular dyskinesia is a major etiological factor in overhead athletes' shoulder problems. Virtual Reality (VR) it allows individuals to interact and train with or within interesting and relatively realistic three-dimensional(3D) environments. VR and its simulated environments are well accepted in entertainment and computer game applications. However, what is not as well recognized is that VR offers the opportunity for intensive repetition of meaningful task-related activities necessary for effective rehabilitation. The scapular stabilization exercise in rehabilitation aims to Restore shoulder function; these exercises are a combination of scapular stabilization exercises, rotator cuff strengthening exercises, range of motion (ROM), proprioceptive neuromuscular facilitation (PNF), and stretching exercises. Physiotherapy is the mainstay management for several musculoskeletal disorders. sixty basketball athletes with dyskinesea will be assigned randomly to three equal groups; the first will receive Virtual reality exercise and routine exercise, and the second group will receive Stabilization exercise and routine exercise. and finally, the third group will receive routine exercise only for eight weeks

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
90

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • ninety basketball players of both genders.
  • Subjects with age between 20 and 25 years old.
  • Subjects with Body Mass Index (BMI) ranging from 18 to 25 kg/m².

Exclusion Criteria:

  • An injury within the four weeks before testing.
  • Upper extremity fractures.
  • Bilateral repetitive strain injuries
  • Osteoarthritis on hand

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: scapular stabilization exercise
thirty patients with scapular dyskinesia will receive scapular stabilization exercise and regular routine three times a week for eight weeks
Other: scapular stabilization exercises
the patients will receive scapular stabilization exercises in the form of scapular orientation exercises,Forward/Backward Bear Crawls,Lateral Bear Crawls and assisted stretch for pectoralis minor
Other: regular routine exercises
the patients will receive routine exercises in the form of Sleeper Stretch: Posterior Capsular Stretch, Push up, Wall slides, Kettlebell High Pull,
Experimental: virtual reality exercise
thirty patients with scapular dyskinesia will receive virtual reality exercise and regular routine three times a week for eight weeks
Other: regular routine exercises
the patients will receive routine exercises in the form of Sleeper Stretch: Posterior Capsular Stretch, Push up, Wall slides, Kettlebell High Pull,
Other: virtual reality exercises

The exercises described were done in a consistent manner, emphasizing low intensity, and using lightweight dumbbells (range, 3 to 30 pounds). The weight of the dumbbell was individually selected by the subject for each exercise.

  1. elevation of the arm in the sagittal plane (shoulder flexion
  2. elevation of the arm in the scapular plane with humeral external rotation (shoulder scaption
  3. elevation of the arm in the coronal plane (shoulder abduction)
  4. rowing
  5. horizontal shoulder abduction
  6. horizontal abduction with humeral external rotation
  7. push-up with hands apart
  8. push-up with a plus-normal push-up adding maximum shoulder and scapular protraction with elbows fully extended
  9. dumbbell bench press
  10. dumbbell military press
  11. shoulder shrug
  12. deceleration exercise-simulating the pitching followthrough
  13. shoulder extension prone
  14. shoulder internal rotation
  15. shoulder external rotation
  16. press-up
Active Comparator: Regular routine exercise
thirty patients with scapular dyskinesia will receive regular routine exercises three times a week for eight weeks
Other: regular routine exercises
the patients will receive routine exercises in the form of Sleeper Stretch: Posterior Capsular Stretch, Push up, Wall slides, Kettlebell High Pull,

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
agonist antagonist ratio
Time Frame: up to eight weeks
isokinetic Biodex 3 dynamometer will be used to assess agonist antagonist ratio
up to eight weeks

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Hand grip strength
Time Frame: up to eight weeks
Jamar handheld dynamometer will be used to assess hand grip strength
up to eight weeks
rounded shoulder posture
Time Frame: up to eight weeks
Patient is supine with the arms at the sides, elbows extended, palms upward, knees bent and lower back flat on the table. The examiner stands at the head of the table and use tape measurements to measure the distance between the acromion of the shoulder joint and the table surface three times. The numbers were averaged and used for analysis. Increased distance signifies higher rounded shoulder posture severity
up to eight weeks
pain intensity level
Time Frame: up to eight weeks
Visual Analogue Scale (VAS) will be used to assess pain by Using a ruler, the score is determined by measuring the distance on the 10-cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-10. A higher score indicates greater pain intensity.
up to eight weeks
The disabilities of the arm, shoulder and hand
Time Frame: up to eight weeks
The disabilities of the arm, shoulder and hand (DASH) questionnaire will be used to assess the disability in arm, shoulder and hand. The DASH consists mainly of a 30- item disability/symptom scale. The possible score ranges from 0 to 100 points. 0 points represent a complete, unrestricted function of the upper extremities, while 100 points represent the greatest possible functional impairment.
up to eight weeks
peak force
Time Frame: up to eight weeks
isokinetic Biodex 3 dynamometer will be used to assess peak force
up to eight weeks
total work
Time Frame: up to eight weeks
isokinetic Biodex 3 dynamometer will be used to assess total work
up to eight weeks
work fatigue
Time Frame: up to eight weeks
isokinetic Biodex 3 dynamometer will be used to assess work fatigue
up to eight weeks
average power
Time Frame: up to eight weeks
isokinetic Biodex 3 dynamometer will be used to assess average power
up to eight weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
March 5, 2024

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
July 30, 2024

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
July 30, 2024

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
January 31, 2024

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 27, 2024

First Posted (Estimated)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
March 5, 2024

Study Record Updates

Last Update Posted (Estimated)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
March 5, 2024

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 27, 2024

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
February 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • P.T.REC/012/003131

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings